Published in Curr Treat Options Neurol on June 01, 2012
Novel approaches and challenges to treatment of central nervous system viral infections. Ann Neurol (2013) 0.90
Neuroinfectious diseases: a crisis in neurology and a call for action. JAMA Neurol (2015) 0.81
Polymorphonuclear Cell Functional Impairment in Relapsing Remitting Multiple Sclerosis Patients: Preliminary Data. PLoS One (2015) 0.75
Primary central nervous system lymphoma in a patient treated with natalizumab. Ann Neurol (2009) 6.96
Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol (2010) 5.03
Immune reconstitution inflammatory syndrome in natalizumab-associated PML. Neurology (2011) 4.63
Adverse effects of biologics: a network meta-analysis and Cochrane overview. Cochrane Database Syst Rev (2011) 3.44
Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team. N Engl J Med (1998) 2.99
Evaluation of combination therapy using aciclovir and corticosteroid in adult patients with herpes simplex virus encephalitis. J Neurol Neurosurg Psychiatry (2005) 2.13
Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function. Neurology (2009) 2.10
Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis. Pediatrics (1997) 2.09
Identification and characterization of mefloquine efficacy against JC virus in vitro. Antimicrob Agents Chemother (2009) 2.02
CMV central nervous system disease in stem-cell transplant recipients: an increasing complication of drug-resistant CMV infection and protracted immunodeficiency. Bone Marrow Transplant (2010) 1.76
Rituximab monotherapy for patients with recurrent primary CNS lymphoma. Neurology (2011) 1.41
A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS. AIDS (2002) 1.39
Activities of various compounds against murine and primate polyomaviruses. Antimicrob Agents Chemother (1997) 1.29
Progressive multifocal leukoencephalopathy and newer biological agents. Drug Saf (2010) 1.28
Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS Clinical Trials Group Protocol 360). Clin Infect Dis (2003) 1.27
EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol (2008) 1.25
The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line. J Neurovirol (1998) 1.11
Predictors of mortality and impact of aminoglycosides on outcome in listeriosis in a retrospective cohort study. J Antimicrob Chemother (2009) 1.10
Tuberculous meningitis. Acta Neurol Scand (2010) 1.09
Dexamethasone adjunctive treatment for tuberculous meningitis. Pediatr Infect Dis J (1991) 1.08
Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case-series of 20 patients. Clin Microbiol Infect (2011) 1.06
Factors associated with cytomegalovirus infection among human immunodeficiency virus type 1-seronegative and -seropositive women from an urban minority community. J Infect Dis (1996) 1.06
Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: a monocenter observational study with clinical and JC virus load monitoring. J Neurovirol (2001) 1.02
Inhibition of human neurotropic virus (JCV) DNA replication in glial cells by camptothecin. Virology (1993) 0.97
Antibiotic treatment for bacterial meningitis caused by Listeria monocytogenes in a patient with multiple myeloma. J Infect Chemother (2010) 0.93
Treatment approaches for primary CNS lymphomas. Expert Opin Pharmacother (2010) 0.89
Biology and treatment of primary central nervous system lymphoma. Neurotherapeutics (2009) 0.88
High incidence of human herpes virus 6-associated encephalitis/myelitis following a second unrelated cord blood transplantation. Biol Blood Marrow Transplant (2010) 0.88
Polymerase chain reaction in the investigation of "relapse" following herpes simplex encephalitis. J Med Virol (1996) 0.85
Herpes simplex virus infection of the central nervous system in human immunodeficiency virus-type 1-infected patients. Int J STD AIDS (2004) 0.83
The management of primary central nervous system lymphoma related to AIDS in the HAART era. Curr Opin Oncol (2011) 0.83
Primary lymphoma of CNS, mycophenolate mofetil and lupus. Lupus (2006) 0.82
Neurologic cytomegalovirus complications in patients with AIDS: retrospective review of 13 cases and review of the literature. Rev Inst Med Trop Sao Paulo (2011) 0.81
Cellular therapy with sequential unmanipulated donor lymphocyte infusions in drug-resistant cytomegalovirus (CMV) encephalitis. Blood (2011) 0.80
Transmission of human herpesvirus 7 through multigenerational families in the same household. Pediatr Infect Dis J (1997) 0.80
Advances in the management of PML: focus on natalizumab. Cleve Clin J Med (2011) 0.80
Ganciclovir-resistant human herpesvirus-6 encephalitis in a liver transplant patient: a case report. J Neurovirol (2011) 0.79
Brain diffuse large B-cell lymphoma in a systemic lupus erythematosus patient treated with immunosuppressive agents including mycophenolate mofetil. Lupus (2011) 0.78
Infections due to human herpesvirus 6 in solid organ transplant recipients. Curr Opin Organ Transplant (2010) 0.78
Use of rituximab in combination with high-dose methotrexate in the treatment of primary central nervous system lymphoma in a mycophenolate mofetil treated patient with lupus nephritis. Acta Oncol (2010) 0.76
Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences. N Engl J Med (2005) 1.85
Delayed fingolimod-associated asystole. Mult Scler (2011) 1.61
Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy. J Virol (2007) 1.52
High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy. J Clin Microbiol (2006) 1.34
Neuroimaging correlates of HIV-associated BBB compromise. J Neuroimmunol (2004) 1.27
The HIV Dementia Scale: predictive power in mild dementia and HAART. J Neurol Sci (2007) 1.23
Persistence and pathogenesis of the neurotropic polyomavirus JC. Ann Neurol (2015) 1.21
Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia. J Neurovirol (2004) 1.15
ALS syndrome in patients with HIV-1 infection. J Neurol Sci (2005) 1.14
Stroke in HIV infection and AIDS. Expert Rev Cardiovasc Ther (2009) 1.09
Update on progressive multifocal leukoencephalopathy. Curr Neurol Neurosci Rep (2012) 1.06
Mass lesions of the brain in AIDS: the dilemmas of distinguishing toxoplasmosis from primary CNS lymphoma. AJNR Am J Neuroradiol (2003) 1.02
Progressive multifocal leukoencephalopathy in a patient with Hodgkin lymphoma treated with brentuximab vedotin. Leuk Lymphoma (2012) 1.02
Isolated Histoplasma capsulatum meningoencephalitis in an immunocompetent child. J Child Neurol (2012) 0.94
Understanding pathogenesis and treatment of HIV dementia: a role for magnetic resonance? Trends Neurosci (2002) 0.94
Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study. Arch Neurol (2009) 0.93
The bone marrow, B cells, and JC virus. J Neurovirol (2008) 0.93
Considerations on discontinuing natalizumab for the treatment of multiple sclerosis. Ann Neurol (2010) 0.93
Steroids for PML-IRIS: a double-edged sword? Neurology (2009) 0.89
Central Nervous System Infections With Immunomodulatory Therapies. Continuum (Minneap Minn) (2015) 0.87
Low prevalence of varicella zoster virus and herpes simplex virus type 2 in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2010) 0.87
Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids following influenza vaccination. Arch Pathol Lab Med (2012) 0.86
The basis for modeling progressive multifocal leukoencephalopathy pathogenesis. Curr Opin Neurol (2011) 0.86
A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy. J Neurovirol (2006) 0.86
Wernicke's encephalopathy in the course of chemoradiotherapy for head and neck cancer. Am J Otolaryngol (2010) 0.86
Progressive multifocal leukoencephalopathy in multiple sclerosis. Curr Neurol Neurosci Rep (2013) 0.85
Ziconotide infusion for severe chronic pain: case series of patients with neuropathic pain. Pharmacotherapy (2006) 0.85
Monofocal acute inflammatory Demyelination (MAID): a unique disorder simulating brain neoplasm. South Med J (2002) 0.84
JCV-specific CD4 T cell response: another piece of the puzzle in explaining some aspects of AIDS associated PML. AIDS (2003) 0.83
Progressive Multifocal Leukoencephalopathy: Recent Advances and a Neuro-Ophthalmological Review. J Neuroophthalmol (2015) 0.83
Substantia nigra depigmentation and exposure to encephalitis lethargica. Ann Neurol (2012) 0.81
Spinal epidural abscess. Curr Infect Dis Rep (2014) 0.81
Infection risk in patients on multiple sclerosis therapeutics. CNS Drugs (2015) 0.81
Alien hand syndrome. Neurology (2006) 0.81
The manifold faces of PML and the challenge of diagnosis. Neurology (2011) 0.79
Introduction to HIV infection and neuro-AIDS. Handb Clin Neurol (2007) 0.79
The changing landscape of progressive multifocal leukoencephalopathy. Curr Infect Dis Rep (2011) 0.79
Cervical myelopathy secondary to violent tics of Tourette's syndrome. Neurology (2003) 0.79
Disease-modifying drugs for multiple sclerosis and JC virus expression. J Neurovirol (2012) 0.79
An international screening tool for HIV dementia. AIDS (2005) 0.78
Autoimmune markers in HIV-associated dementia. J Neuroimmunol (2003) 0.78
Reply to "'Thinking without thinking' about natalizumab and PML". J Neurol Sci (2007) 0.78
Primary lateral sclerosis with HIV-1 infection. Neurology (2008) 0.77
HIV and the central nervous system. Compr Ther (2002) 0.77
Too much of a good thing? IRIS with natalizumab-associated PML. Neurology (2011) 0.77
Genetic testing and HIV dementia: teasing out the molecular mechanisms of disease. AIDS (2010) 0.76
Identification of potential antibody markers in HIV-associated dementia. J Neuroimmunol (2004) 0.76
Parinaud syndrome heralding MS. Neurology (2003) 0.75
Memory and the mammillothalamic tract. AJNR Am J Neuroradiol (2004) 0.75
Multiple sclerosis remission following antiretroviral therapy in an HIV-infected man. J Neurovirol (2014) 0.75
Is the presence of antibodies in CSF sufficient to make a definitive diagnosis of Lyme disease? Neurology (2007) 0.75
Volitional opsoclonus. Neurology (2005) 0.75
Against all odds: surviving rhino-orbital-cerebral mucormycosis: a case report. J Neurovirol (2012) 0.75
Presumptive human herpesvirus 6 myelopathy in an immunocompetent patient. J Neurovirol (2014) 0.75
Neuro-AIDS in the developing world. Neurology (2012) 0.75
Acute central cord syndrome with bodybuilder sign. Clin Neurol Neurosurg (2007) 0.75
Hereditary hemorrhagic telangectasia and spinal cord infarct: case report with a review of the neurological complications of HHT. Clin Neurol Neurosurg (2008) 0.75
Homonymous hemianopsia complicating treatment of postoperative epistaxis. Neurology (2006) 0.75
Iatrogenic fungal infections of central nervous system. Curr Neurol Neurosci Rep (2013) 0.75
Progressive multifocal leukoencephalopathy. Handb Clin Neurol (2007) 0.75
Infectious myelopathies. Continuum (Minneap Minn) (2011) 0.75
Other opportunistic infections of the central nervous system in AIDS. Handb Clin Neurol (2007) 0.75
The interface of infectious disease and neuro-ophthalmology. J Neuroophthalmol (2012) 0.75
Proceedings of the 10th International Conference on Neuroscience of HIV Infection: emerging issues. J Neurovirol (2002) 0.75
A giant MS plaque mimicking PML during natalizumab treatment. J Neurol Sci (2010) 0.75